{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:34:36Z","timestamp":1772483676642,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ygyno.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:52:54Z","timestamp":1559267574000},"page":"302-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma"],"prefix":"10.1016","volume":"154","author":[{"given":"Dimitrios","family":"Nasioudis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley F.","family":"Haggerty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Robert L.","family":"Giuntoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawar A.","family":"Latif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ygyno.2019.05.009_bb0005","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra1813254","article-title":"Mucinous Ovarian Carcinoma","volume":"380","author":"Morice","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2019.05.009_bb0010","doi-asserted-by":"crossref","first-page":"i53","DOI":"10.1093\/annonc\/mdw087","article-title":"Mucinous epithelial ovarian carcinoma","volume":"27","author":"Perren","year":"2016","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2019.05.009_bb0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/IGC.0000000000000932","article-title":"Relatively poor survival of mucinous ovarian carcinoma in advanced stage: a systematic review and meta-analysis","volume":"27","author":"Simons","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2019.05.009_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00404-018-4789-2","article-title":"Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?","volume":"298","author":"Nasioudis","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.ygyno.2019.05.009_bb0025","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ygyno.2016.11.038","article-title":"Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma","volume":"144","author":"Nasioudis","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.05.009_bb0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2009.10.073","article-title":"The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a gynecologic oncology group study","volume":"116","author":"Chan","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"9 Suppl 3","key":"10.1016\/j.ygyno.2019.05.009_bb0035","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/IGC.0000000000000296","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for mucinous ovarian carcinoma","volume":"24","author":"Ledermann","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2019.05.009_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.113","volume":"95","author":"Trimbos","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2019.05.009_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/95.2.125","article-title":"International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer","volume":"95","author":"Colombo","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.ygyno.2019.05.009_bb0050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.6004\/jnccn.2016.0122","article-title":"Ovarian Cancer, version 1.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Morgan","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"Suppl. 6","key":"10.1016\/j.ygyno.2019.05.009_bb0055","doi-asserted-by":"crossref","first-page":"vi24","DOI":"10.1093\/annonc\/mdt333","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Ledermann","year":"2013","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.05.009_bb0060","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2019.05.009_bb0065","series-title":"Cancer Incidence in Five Continents Vol. X IARC Scientific Publication No 164","year":"2014"},{"issue":"1","key":"10.1016\/j.ygyno.2019.05.009_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2018.04.567","article-title":"Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: patterns of use and outcomes","volume":"150","author":"Nasioudis","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.05.009_bb0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/AOG.0000000000001867","article-title":"Outcomes of women with high-grade and low-grade advanced-stage serous epithelial ovarian cancer","volume":"129","author":"Gockley","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.05.009_bb0080","unstructured":"Joinpoint Regression Program, Version 4.6.0.0 - April 2018; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute."},{"issue":"1","key":"10.1016\/j.ygyno.2019.05.009_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1535-7163.MCT-17-1050","article-title":"PRKRA\/PACT expression promotes chemoresistance of mucinous ovarian cancer","volume":"18","author":"Hisamatsu","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.ygyno.2019.05.009_bb0090","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/annonc\/mdq257","article-title":"Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience","volume":"21","author":"Alexandre","year":"2010","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2019.05.009_bb0095","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/IGC.0000000000001263","article-title":"International study of primary mucinous ovarian carcinomas managed at tertiary medical centers","volume":"28","author":"Mueller","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2019.05.009_bb0100","unstructured":"Gore ME, Hackshaw A, Brady WE, et al. Multicentre trial of carboplatin\/paclitaxel versus oxaliplatin\/capecitabine, each with\/without bevacizumab, as first line chemotherapy for patients with mucinous epithelial ovarian cancer (mEOC). As Presented at the 2015 ASCO Annual Meeting. Available at: http:\/\/meetinglibrary.asco.org\/content\/145864-156 (abstract 5528)."},{"key":"10.1016\/j.ygyno.2019.05.009_bb0105","doi-asserted-by":"crossref","unstructured":"B. Schlappe, Q. Zhou, R. O'Cearbhaill, et al. Comparison of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen June 2018 vol. 149, Supplement 1, 236.","DOI":"10.1016\/j.ygyno.2018.04.531"},{"issue":"1","key":"10.1016\/j.ygyno.2019.05.009_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.05.008","article-title":"Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses","volume":"150","author":"Mueller","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.05.009_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/IGC.0000000000001202","article-title":"Characteristics and prognosis of stage I ovarian mucinous tumors according to expansile or infiltrative type","volume":"28","author":"Gouy","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2019.05.009_bb0120","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ejca.2012.12.004","article-title":"Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases","volume":"49","author":"Muyldermans","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2019.05.009_bb0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cncr.25453","article-title":"Mucinous ovarian carcinoma: slippery business","volume":"117","author":"Soslow","year":"2011","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819312338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819312338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:46:13Z","timestamp":1758771973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819312338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0090825819312338"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.05.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}